---
annotation-target: qu2020.pdf
---


>%%
>```annotation-json
>{"created":"2022-08-08T06:14:59.407Z","updated":"2022-08-08T06:14:59.407Z","document":{"title":"Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia","link":[{"href":"urn:x-pdf:1801e8269908c88a840c73f2e56bcd49"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf"}],"documentFingerprint":"1801e8269908c88a840c73f2e56bcd49"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","selector":[{"type":"TextPositionSelector","start":277,"end":291},{"type":"TextQuoteSelector","exact":" RNA HOXA‐AS2 ","prefix":"Overexpression of long noncoding","suffix":"predictsan adverse prognosis and"}]}]}
>```
>%%
>*%%PREFIX%%Overexpression of long noncoding%%HIGHLIGHT%% ==RNA HOXA‐AS2== %%POSTFIX%%predictsan adverse prognosis and*
>%%LINK%%[[#^slq5ettdl8|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^slq5ettdl8


>%%
>```annotation-json
>{"created":"2022-08-08T06:15:41.365Z","updated":"2022-08-08T06:15:41.365Z","document":{"title":"Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia","link":[{"href":"urn:x-pdf:1801e8269908c88a840c73f2e56bcd49"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf"}],"documentFingerprint":"1801e8269908c88a840c73f2e56bcd49"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","selector":[{"type":"TextPositionSelector","start":996,"end":1093},{"type":"TextQuoteSelector","exact":"Long noncoding RNAs (lncRNAs) play important roles in diverse cellular processesand carcinogenesi","prefix":"t/Award Number: 2014‐253Abstract","suffix":"s. Homeobox A cluster antisense "}]}]}
>```
>%%
>*%%PREFIX%%t/Award Number: 2014‐253Abstract%%HIGHLIGHT%% ==Long noncoding RNAs (lncRNAs) play important roles in diverse cellular processesand carcinogenesi== %%POSTFIX%%s. Homeobox A cluster antisense*
>%%LINK%%[[#^4r1wzdckri5|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^4r1wzdckri5


>%%
>```annotation-json
>{"created":"2022-08-08T06:16:20.445Z","updated":"2022-08-08T06:16:20.445Z","document":{"title":"Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia","link":[{"href":"urn:x-pdf:1801e8269908c88a840c73f2e56bcd49"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf"}],"documentFingerprint":"1801e8269908c88a840c73f2e56bcd49"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","selector":[{"type":"TextPositionSelector","start":1220,"end":1402},{"type":"TextQuoteSelector","exact":"overactivation was previously found to promote the proliferation and invasion ofsolid tumors. However, its clinical and biological roles in acute myeloid leukemia(AML) remain unclear","prefix":"man HOXA3 and HOXA4 genes, whose","suffix":". This study showed that HOXA‐AS"}]}]}
>```
>%%
>*%%PREFIX%%man HOXA3 and HOXA4 genes, whose%%HIGHLIGHT%% ==overactivation was previously found to promote the proliferation and invasion ofsolid tumors. However, its clinical and biological roles in acute myeloid leukemia(AML) remain unclear== %%POSTFIX%%. This study showed that HOXA‐AS*
>%%LINK%%[[#^y0jpdkk0s7|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^y0jpdkk0s7


>%%
>```annotation-json
>{"created":"2022-08-08T06:17:14.321Z","updated":"2022-08-08T06:17:14.321Z","document":{"title":"Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia","link":[{"href":"urn:x-pdf:1801e8269908c88a840c73f2e56bcd49"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf"}],"documentFingerprint":"1801e8269908c88a840c73f2e56bcd49"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","selector":[{"type":"TextPositionSelector","start":1705,"end":2201},{"type":"TextQuoteSelector","exact":"a tendency toward inferior survival in patients with high HOXA‐AS2 ex-pression, and HOXA‐AS2 was an independent prognostic factor among the normal‐karyotype AMLs. Furthermore, the results of in vitro study showed that silencingHOXA‐AS2 significantly inhibited the growth of leukemic cells by inducing G1/G0‐phase arrest and apoptosis. Further analysis demonstrated that silencing HOXA‐AS2suppressed the phosphorylation level of PI3K and AKT, which thereafter promotedthe expression of P21 and P27","prefix":"nd earlier death. Therewas also ","suffix":". Moreover, it was suggested tha"}]}]}
>```
>%%
>*%%PREFIX%%nd earlier death. Therewas also%%HIGHLIGHT%% ==a tendency toward inferior survival in patients with high HOXA‐AS2 ex-pression, and HOXA‐AS2 was an independent prognostic factor among the normal‐karyotype AMLs. Furthermore, the results of in vitro study showed that silencingHOXA‐AS2 significantly inhibited the growth of leukemic cells by inducing G1/G0‐phase arrest and apoptosis. Further analysis demonstrated that silencing HOXA‐AS2suppressed the phosphorylation level of PI3K and AKT, which thereafter promotedthe expression of P21 and P27== %%POSTFIX%%. Moreover, it was suggested tha*
>%%LINK%%[[#^rm32wd87ekb|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^rm32wd87ekb


>%%
>```annotation-json
>{"created":"2022-08-08T06:17:29.695Z","updated":"2022-08-08T06:17:29.695Z","document":{"title":"Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia","link":[{"href":"urn:x-pdf:1801e8269908c88a840c73f2e56bcd49"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf"}],"documentFingerprint":"1801e8269908c88a840c73f2e56bcd49"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","selector":[{"type":"TextPositionSelector","start":2261,"end":2550},{"type":"TextQuoteSelector","exact":"Y‐box 4 (SOX4), which is closely involved in the PI3K/AKT pathway, might beone of the major downstream targets of HOXA‐AS2. Silencing HOXA‐AS2 decreasedthe expression of SOX4, whereas the upregulation of SOX4 partially abrogated theinhibitory effect of silencing HOXA‐AS2 on leukemic cells","prefix":" that the sex‐determiningregion ","suffix":". In conclusion, thesefindings s"}]}]}
>```
>%%
>*%%PREFIX%%that the sex‐determiningregion%%HIGHLIGHT%% ==Y‐box 4 (SOX4), which is closely involved in the PI3K/AKT pathway, might beone of the major downstream targets of HOXA‐AS2. Silencing HOXA‐AS2 decreasedthe expression of SOX4, whereas the upregulation of SOX4 partially abrogated theinhibitory effect of silencing HOXA‐AS2 on leukemic cells== %%POSTFIX%%. In conclusion, thesefindings s*
>%%LINK%%[[#^w3uzbgg9nvd|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^w3uzbgg9nvd


>%%
>```annotation-json
>{"created":"2022-08-08T06:23:04.605Z","updated":"2022-08-08T06:23:04.605Z","document":{"title":"Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia","link":[{"href":"urn:x-pdf:1801e8269908c88a840c73f2e56bcd49"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf"}],"documentFingerprint":"1801e8269908c88a840c73f2e56bcd49"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","selector":[{"type":"TextPositionSelector","start":3606,"end":3719},{"type":"TextQuoteSelector","exact":"aberrant myeloid blast proliferation and severe differentiationblockage, leading to hematopoietic insufficiency (","prefix":"em cells. It is characterized by","suffix":"Dohner,Weisdorf, & Bloomfield, 2"}]}]}
>```
>%%
>*%%PREFIX%%em cells. It is characterized by%%HIGHLIGHT%% ==aberrant myeloid blast proliferation and severe differentiationblockage, leading to hematopoietic insufficiency (== %%POSTFIX%%Dohner,Weisdorf, & Bloomfield, 2*
>%%LINK%%[[#^g6vua7rz78|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^g6vua7rz78


>%%
>```annotation-json
>{"created":"2022-08-08T06:23:34.117Z","updated":"2022-08-08T06:23:34.117Z","document":{"title":"Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia","link":[{"href":"urn:x-pdf:1801e8269908c88a840c73f2e56bcd49"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf"}],"documentFingerprint":"1801e8269908c88a840c73f2e56bcd49"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","selector":[{"type":"TextPositionSelector","start":4054,"end":4352},{"type":"TextQuoteSelector","exact":"Despitesignificant advances in the molecular targeting therapy of AML, theoverall survival still needs improvement and the accurate biomarkersassociated with the prognosis demand more solid data. Therefore,the key factors for the pathogenesis and clinical relevance of AMLneed further investigation","prefix":"ts (Papaemmanuil et al., 2016). ","suffix":".Long noncoding RNAs (lncRNAs) a"}]}]}
>```
>%%
>*%%PREFIX%%ts (Papaemmanuil et al., 2016).%%HIGHLIGHT%% ==Despitesignificant advances in the molecular targeting therapy of AML, theoverall survival still needs improvement and the accurate biomarkersassociated with the prognosis demand more solid data. Therefore,the key factors for the pathogenesis and clinical relevance of AMLneed further investigation== %%POSTFIX%%.Long noncoding RNAs (lncRNAs) a*
>%%LINK%%[[#^0n3nvtpl4vri|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^0n3nvtpl4vri


>%%
>```annotation-json
>{"created":"2022-08-08T06:24:14.382Z","updated":"2022-08-08T06:24:14.382Z","document":{"title":"Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia","link":[{"href":"urn:x-pdf:1801e8269908c88a840c73f2e56bcd49"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf"}],"documentFingerprint":"1801e8269908c88a840c73f2e56bcd49"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","selector":[{"type":"TextPositionSelector","start":5008,"end":5095},{"type":"TextQuoteSelector","exact":"HOTAIR promotedthe growth and inhibited apoptosis of leukemic cells by modulating c‐Kit","prefix":"ao et al., 2017). For instance, ","suffix":"(Xing et al., 2015), whereas lnc"}]}]}
>```
>%%
>*%%PREFIX%%ao et al., 2017). For instance,%%HIGHLIGHT%% ==HOTAIR promotedthe growth and inhibited apoptosis of leukemic cells by modulating c‐Kit== %%POSTFIX%%(Xing et al., 2015), whereas lnc*
>%%LINK%%[[#^ejcpev929mg|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^ejcpev929mg


>%%
>```annotation-json
>{"created":"2022-08-08T06:26:13.739Z","updated":"2022-08-08T06:26:13.739Z","document":{"title":"Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia","link":[{"href":"urn:x-pdf:1801e8269908c88a840c73f2e56bcd49"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf"}],"documentFingerprint":"1801e8269908c88a840c73f2e56bcd49"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","selector":[{"type":"TextPositionSelector","start":6756,"end":7131},{"type":"TextQuoteSelector","exact":"The present study revealed the clinical relevance of HOXA‐AS2in AML patients and explored its potential role in the growth ofleukemic cells. The results suggested that HOXA‐AS2 probablyfunctions as an oncogene by modulating the SOX4/PI3K/AKT path-way and might be a valuable biomarker for the prognostic predictionof AML as well as a potential therapeutic target for leukemia","prefix":"AS2 in leukemia remains unclear.","suffix":".2 | MATERIALS AND METHODS2.1 | "}]}]}
>```
>%%
>*%%PREFIX%%AS2 in leukemia remains unclear.%%HIGHLIGHT%% ==The present study revealed the clinical relevance of HOXA‐AS2in AML patients and explored its potential role in the growth ofleukemic cells. The results suggested that HOXA‐AS2 probablyfunctions as an oncogene by modulating the SOX4/PI3K/AKT path-way and might be a valuable biomarker for the prognostic predictionof AML as well as a potential therapeutic target for leukemia== %%POSTFIX%%.2 | MATERIALS AND METHODS2.1 |*
>%%LINK%%[[#^uau6g7ougol|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^uau6g7ougol


>%%
>```annotation-json
>{"created":"2022-08-08T06:27:50.365Z","updated":"2022-08-08T06:27:50.365Z","document":{"title":"Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia","link":[{"href":"urn:x-pdf:1801e8269908c88a840c73f2e56bcd49"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf"}],"documentFingerprint":"1801e8269908c88a840c73f2e56bcd49"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","selector":[{"type":"TextPositionSelector","start":17726,"end":17734},{"type":"TextQuoteSelector","exact":"GraphPad","prefix":"T AL.2.11 | Statistical analysis","suffix":" Prism 6.0 (GraphPad Software, C"}]}]}
>```
>%%
>*%%PREFIX%%T AL.2.11 | Statistical analysis%%HIGHLIGHT%% ==GraphPad== %%POSTFIX%%Prism 6.0 (GraphPad Software, C*
>%%LINK%%[[#^plntmgkwlyn|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^plntmgkwlyn


>%%
>```annotation-json
>{"created":"2022-08-08T06:27:54.906Z","updated":"2022-08-08T06:27:54.906Z","document":{"title":"Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia","link":[{"href":"urn:x-pdf:1801e8269908c88a840c73f2e56bcd49"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf"}],"documentFingerprint":"1801e8269908c88a840c73f2e56bcd49"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","selector":[{"type":"TextPositionSelector","start":17772,"end":17777},{"type":"TextQuoteSelector","exact":" SPSS","prefix":" 6.0 (GraphPad Software, CA) and","suffix":" 22.0 (IBMCorp, Armonk, NY) stat"}]}]}
>```
>%%
>*%%PREFIX%%6.0 (GraphPad Software, CA) and%%HIGHLIGHT%% ==SPSS== %%POSTFIX%%22.0 (IBMCorp, Armonk, NY) stat*
>%%LINK%%[[#^jk89difq5dm|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^jk89difq5dm


>%%
>```annotation-json
>{"created":"2022-08-08T06:28:30.198Z","updated":"2022-08-08T06:28:30.198Z","document":{"title":"Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia","link":[{"href":"urn:x-pdf:1801e8269908c88a840c73f2e56bcd49"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf"}],"documentFingerprint":"1801e8269908c88a840c73f2e56bcd49"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","selector":[{"type":"TextPositionSelector","start":17854,"end":18426},{"type":"TextQuoteSelector","exact":"Normally distributed continuous variables were presented as mean±standard deviation and analyzed using Student's t test, one‐or two‐way analysis of variance, whereas non‐normal distributed parameterswere presented as median with interquartile range or frequencyusing the Wilcoxon rank‐sum test for the difference analysis. Pear-son's χ2 analysis or Fisher's exact test was used to compare thedifference in categorical variables. Survival probabilities were esti-mated using the Kaplan–Meier method, and differences in patientsurvival were compared using the log‐rank test.","prefix":"are were used for data analysis.","suffix":" Univariate andmultivariate anal"}]}]}
>```
>%%
>*%%PREFIX%%are were used for data analysis.%%HIGHLIGHT%% ==Normally distributed continuous variables were presented as mean±standard deviation and analyzed using Student's t test, one‐or two‐way analysis of variance, whereas non‐normal distributed parameterswere presented as median with interquartile range or frequencyusing the Wilcoxon rank‐sum test for the difference analysis. Pear-son's χ2 analysis or Fisher's exact test was used to compare thedifference in categorical variables. Survival probabilities were esti-mated using the Kaplan–Meier method, and differences in patientsurvival were compared using the log‐rank test.== %%POSTFIX%%Univariate andmultivariate anal*
>%%LINK%%[[#^art8rjfnwoa|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^art8rjfnwoa


>%%
>```annotation-json
>{"created":"2022-08-08T06:30:20.716Z","updated":"2022-08-08T06:30:20.716Z","document":{"title":"Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia","link":[{"href":"urn:x-pdf:1801e8269908c88a840c73f2e56bcd49"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf"}],"documentFingerprint":"1801e8269908c88a840c73f2e56bcd49"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/qu2020.pdf","selector":[{"type":"TextPositionSelector","start":37847,"end":39274},{"type":"TextQuoteSelector","exact":" HOXA‐AS2 might serve as apotential biomarker for prognosis and MRD monitoring in AML patients.FIGURE 7 HOXA‐AS2 silencing inhibited the SOX4/PI3K/AKT pathway. (b) The expression of SOX4 were measured by qRT‐PCR andwestern blot assay in HL‐60 and K562 cells infected with HOXA‐AS2 shRNA or shRNA control. Data were presented as mean±SD of threeindependent experiments. ***p < .001 compared with the shRNA control. (b) The expression of SOX4 was investigated in AML patients and celllines by qRT‐PCR. Clinical data were presented as median with interquartile range or frequency; experimental data of AML cell lines werepresented as mean±SD of three independent experiments. *p < .05, **p < .01, and ***p < .001 compared with the control. (c) The correlationbetween SOX4 and HOXA‐AS2 expression was proved by Pearson's correlation method. (d–g) The protein level of total PI3K, p‐PI3K, total AKT,p‐AKT, P21, and P27 in HL‐60 and K562 cells infected with HOXA‐AS2 shRNA and shRNA control was analyzed by western blot assay. Datawere presented as mean±SD of three independent experiments. AML, acute myeloid leukemia; HOXA‐AS2, homeobox A cluster antisense RNA2; qRT‐PCR, quantitative real‐time polymerase chain reaction assay; SD, standard deviation; shRNA, short hairpin RNA; SOX4, sex‐determiningregion Y‐box 4. **p < .01 and ***p < .001 compared with the shRNA control12 | CCell ell BBiologyiology    IInternationalnternational","prefix":"disease status. It suggests that","suffix":"QU ET AL.Despite rapid developme"}]}]}
>```
>%%
>*%%PREFIX%%disease status. It suggests that%%HIGHLIGHT%% ==HOXA‐AS2 might serve as apotential biomarker for prognosis and MRD monitoring in AML patients.FIGURE 7 HOXA‐AS2 silencing inhibited the SOX4/PI3K/AKT pathway. (b) The expression of SOX4 were measured by qRT‐PCR andwestern blot assay in HL‐60 and K562 cells infected with HOXA‐AS2 shRNA or shRNA control. Data were presented as mean±SD of threeindependent experiments. ***p < .001 compared with the shRNA control. (b) The expression of SOX4 was investigated in AML patients and celllines by qRT‐PCR. Clinical data were presented as median with interquartile range or frequency; experimental data of AML cell lines werepresented as mean±SD of three independent experiments. *p < .05, **p < .01, and ***p < .001 compared with the control. (c) The correlationbetween SOX4 and HOXA‐AS2 expression was proved by Pearson's correlation method. (d–g) The protein level of total PI3K, p‐PI3K, total AKT,p‐AKT, P21, and P27 in HL‐60 and K562 cells infected with HOXA‐AS2 shRNA and shRNA control was analyzed by western blot assay. Datawere presented as mean±SD of three independent experiments. AML, acute myeloid leukemia; HOXA‐AS2, homeobox A cluster antisense RNA2; qRT‐PCR, quantitative real‐time polymerase chain reaction assay; SD, standard deviation; shRNA, short hairpin RNA; SOX4, sex‐determiningregion Y‐box 4. **p < .01 and ***p < .001 compared with the shRNA control12 | CCell ell BBiologyiology    IInternationalnternational== %%POSTFIX%%QU ET AL.Despite rapid developme*
>%%LINK%%[[#^91cwahqieo9|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^91cwahqieo9
